ADMIN
Go to KTCVS
학술대회 안내
학술대회 안내
인사말
프로그램
1일차(10/29) 일정
2일차(10/30) 일정
3일차(10/31) 일정
Poster Session
사전등록
지도전문의 안내
체외순환사교육
필수과목 이수 안내
사전등록 안내
사전등록
사전등록 현황
초록접수
초록접수 안내
초록접수
초록수정
초록심사
학술상
학술상 안내
학술상 신청 및 접수
학회장/숙박 안내
행사장 안내
찾아오시는 길/교통 안내
셔틀버스 운행 안내
숙박 안내
주변 안내
전시 및 광고
전시안내
전시/부스 신청
부스배치도
News & Notice
초록접수
초록접수 안내
초록접수
초록수정
초록심사
초록접수 현황
선택
접수번호
발표번호
제목
발표자
검색결과
311
건
발표번호
초록제목
발표자
책임저자
13:30-13:40 (O)26-3
Nationwide Outcomes of Local-Stage Lung Cancer Treatment in Patients Aged 80 and Above in Korea : Data from Cancer Public Library Database
Yongwoo Chung
Jin-Ho Choi
14:20-14:30 (O)26-4
Postoperative Pulmonary Function in Stage I–II NSCLC: A Comparative Analysis using Preoperative Spirometry Classification
Odbaatar Myagmar
Joonseok Lee
13:50-14:00 (O)26-5
Prognostic Impact of Interstitial Lung Abnormalities in Resected Lung Cancer
Joonseok Lee
Jae Hyun Jeon
14:00-14:10 (O)26-6
Prognostic Impact of Extracapsular Extension of Lymph Nodes in Resected Lung Cancer Analysis by New N Subcategories and Histologic Types
Shia Kim
Jae Kwang Yun
14:10-14:20 (O)26-7
Development and Validation of a Machine Learning Model for Postoperative Survival in Lung Adenocarcinoma
Yelee Kwon
Hyeong Ryul Kim
14:20-14:30 (O)26-8
Short- and Long-Term Risks of Atrial Fibrillation in Lung Cancer Survivors According to Treatment Modality: A Korean Nationwide Study
Dong Woog Yoon
Jong Ho Cho
15:00-15:10 (O)27-0
Tumor Microenvironment Dynamics in Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
Tae Hee Hong
Dae Joon Kim
15:10-15:20 (O)27-1
Low Recurrence but Notable Intercurrent Mortality after Radical Esophagectomy for pN0 ESCC : A Risk Factor Analysis for Overall Survival
Dae Joon Kim
Dae Joon Kim
15:20-15:30 (O)27-2
Therapeutic Value of Cervical Lymph Node Dissection in ESCC: Outcomes and Efficacy Index-Based Assessment
Dae Joon Kim
Dae Joon Kim
15:30-15:40 (O)27-3
Optimal Number of Bilateral Recurrent Laryngeal Nerve Lymph Node Dissection for Adequate Nodal Staging and Improved Survival in Esophageal Squamous Cell Carcinoma after Neoadjuvant Concurrent Chemoradiotherapy
Yeong Jeong Jeon
Seong Yong Park
15:40-15:50 (O)27-4
Prognostic Value of Tumor Size in T1–2 Stage Esophageal Cancer Patients
Yo Han Bae
Jae Kwang Yun
15:50-16:00 (O)27-5
LODDS as a Robust Predictor of Early Recurrence after Radical Esophagectomy for cT3 ESCC
Dae Joon Kim
Dae Joon Kim
16:00-16:10 (O)28-0
Causes of Death by Time and Treatment Modality in Surgically Treated Esophageal Cancer Patients: A Korean Nationwide Study
Dong Woog Yoon
Jong Ho Cho
16:10-16:20 (O)28-1
The Impact of Metformin Use During Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A Propensity Score Matched Nationwide Study
Taeyoung Yun
Chang Hyun Kang
16:20-16:30 (O)28-2
Results of Endoscopic Treatment for Anastomotic Leakage after Esophagectomy
Yongwoo Chung
JongMog Lee
16:30-16:40 (O)28-3
Prospective Observational Study of Intraoperative Right Gastroepiploic Artery Flow and Anastomosis Level (Distance from Upper Incisors) in Ivor-Lewis Esophagectomy
Gongmin Rim
Young Mok Shim
16:40-16:50 (O)28-4
Neoadjuvant Chemoradiotherapy versus Upfront Surgery in Clinically Single Lymph Node Metastatic Esophageal Cancer
Ji Yong Kim
Hyeong Ryul Kim
17:00-17:10 (O)30-0
Surgical Closure of Isolated Perimembranous Ventricular Septal Defect in Children: Contemporary Outcomes
Ilkun Park
Ji-Hyuk Yang
17:10-17:20 (O)30-1
Surgical Outcomes of Subarterial Ventricular Septal Defect
Dong Hee Jang
Tae-Jin Yun
17:20-17:30 (O)30-2
Atrial Septal Defect Closure in Adults with Pulmonary Hypertension
Sang On Lee
Yu Rim Shin